NEXGEL, Inc. (NXGL) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Langhorne, PA, United States. The current CEO is Adam R. Levy.
NXGL has IPO date of 2021-12-22, 19 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $6.34M.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
